Highlights
NASDAQ: TRIL       Trillium Therapeutic
Last Price Today's Change   Day's Range   Trading Volume
0.554   +0.074 (15.42%)  0.50 - 0.58  3,323,400

Overview

 
Avg Volume (4 weeks):981,863
4 Weeks Range:0.254 - 0.59
4 Weeks Price Volatility (%):
89.29%
52 Weeks Range:0.241 - 2.13
52 Weeks Price Volatility (%):
16.57%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Trillium Therapeutics Inc is a Canadian clinical stage immuno-oncology company which is engaged in developing therapies for the treatment of cancer. The lead program of the company is TTI-621 which is designed to act as a soluble decoy receptor, preventing CD47 from delivering its inhibitory signal. The company has proprietary medicinal chemistry platform, using fluorine chemistry which permits the creation of new chemical entities with pharmacological properties. The company operates through the single segment being Research and development of therapies for the treatment of cancer.

  Be the first to like this.
 


 

3995  4101  641  182 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CELG 108.24+0.11 
 EEM 44.42-0.02 
 SPY 317.32+0.19 
 AMD 41.15-1.44 
 VXX 15.53-0.67 
 DHR 148.52-2.78 
 CHK 0.789+0.006 
 FXI 42.60-0.18 
 GE 11.34-0.10 
 BAC 34.44-0.24 
Partners & Brokers